JP2019506840A - 抗ウイルス剤としてのペプチドおよびこのための使用 - Google Patents

抗ウイルス剤としてのペプチドおよびこのための使用 Download PDF

Info

Publication number
JP2019506840A
JP2019506840A JP2018526142A JP2018526142A JP2019506840A JP 2019506840 A JP2019506840 A JP 2019506840A JP 2018526142 A JP2018526142 A JP 2018526142A JP 2018526142 A JP2018526142 A JP 2018526142A JP 2019506840 A JP2019506840 A JP 2019506840A
Authority
JP
Japan
Prior art keywords
peptide
peptides
influenza
peptide according
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018526142A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506840A5 (enExample
Inventor
イブラヒム，モハメド ラジク モハメド
イブラヒム，モハメド ラジク モハメド
Original Assignee
ヴィラマティクス エスディーエヌ ビーエイチディー
ヴィラマティクス エスディーエヌ ビーエイチディー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴィラマティクス エスディーエヌ ビーエイチディー, ヴィラマティクス エスディーエヌ ビーエイチディー filed Critical ヴィラマティクス エスディーエヌ ビーエイチディー
Publication of JP2019506840A publication Critical patent/JP2019506840A/ja
Publication of JP2019506840A5 publication Critical patent/JP2019506840A5/ja
Priority to JP2022029519A priority Critical patent/JP2022088370A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018526142A 2015-11-27 2016-11-28 抗ウイルス剤としてのペプチドおよびこのための使用 Pending JP2019506840A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022029519A JP2022088370A (ja) 2015-11-27 2022-02-28 抗ウイルス剤としてのペプチドおよびこのための使用

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
MYPI2015002751A MY184269A (en) 2015-11-27 2015-11-27 Broad-spectrum anti-influenza virus therapeutic peptides
MYPI2015002751 2015-11-27
US201662335201P 2016-05-12 2016-05-12
US62/335,201 2016-05-12
US201662425913P 2016-11-23 2016-11-23
US62/425,913 2016-11-23
PCT/IB2016/057146 WO2017090010A1 (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022029519A Division JP2022088370A (ja) 2015-11-27 2022-02-28 抗ウイルス剤としてのペプチドおよびこのための使用

Publications (2)

Publication Number Publication Date
JP2019506840A true JP2019506840A (ja) 2019-03-14
JP2019506840A5 JP2019506840A5 (enExample) 2020-01-09

Family

ID=58763140

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018526142A Pending JP2019506840A (ja) 2015-11-27 2016-11-28 抗ウイルス剤としてのペプチドおよびこのための使用
JP2022029519A Pending JP2022088370A (ja) 2015-11-27 2022-02-28 抗ウイルス剤としてのペプチドおよびこのための使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022029519A Pending JP2022088370A (ja) 2015-11-27 2022-02-28 抗ウイルス剤としてのペプチドおよびこのための使用

Country Status (7)

Country Link
US (1) US10538554B2 (enExample)
EP (1) EP3380493A4 (enExample)
JP (2) JP2019506840A (enExample)
CN (1) CN108699113A (enExample)
AU (1) AU2016359545B2 (enExample)
MY (2) MY184269A (enExample)
WO (1) WO2017090010A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200012894A (ko) * 2017-05-26 2020-02-05 비라매틱스 에스디엔 비에이치디 펩타이드 및 항바이러스제로서의 이의 용도
CN115244067A (zh) * 2019-08-29 2022-10-25 Ajk生物制药有限责任公司 合成抗微生物肽
CN111100194B (zh) * 2020-02-21 2022-03-25 佛山科学技术学院 一种抗菌肽pd-l4在抑制禽流感病毒中的应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004535784A (ja) * 2001-03-22 2004-12-02 アメリカ合衆国 グリコシル化抵抗性シアノビリン及び関連コンジュゲート、組成物、核酸、ベクター、宿主細胞、非グリコシル化シアノビリンの製造方法及び使用方法
JP2005536456A (ja) * 2002-04-05 2005-12-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アテローム性硬化症を改善するｇ−タイプペプチド
JP2011522561A (ja) * 2008-06-12 2011-08-04 ユニバーシティー プトラ マレーシア トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド
JP2011524373A (ja) * 2008-06-13 2011-09-01 ウィスコンシン・アルムナイ・リサーチ・ファウンデーション インフルエンザウイルスに対する新規抗ウイルスペプチド
JP2013538564A (ja) * 2010-07-28 2013-10-17 ユニヴァーシティ コート オブ ザ ユニバーシティ オブ エディンバラ 抗ウイルス剤
CN103360469A (zh) * 2004-05-04 2013-10-23 诺维信阿德宁生物技术公司 抗微生物多肽
WO2014210454A1 (en) * 2013-06-27 2014-12-31 Rutgers, The State University Of New Jersey Treatment and diagnosis of ocular disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007015105A (es) * 2005-06-01 2008-03-18 Variation Biotechnologies Inc Formulacion de vacuna de influenza a base de peptido.
CA2624153A1 (en) 2005-09-29 2007-04-12 The Scripps Research Institute Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family
GB0718966D0 (en) * 2007-09-28 2007-11-07 Liverpool School Of Tropical M Bacterial vaccine
BR112014013853A2 (pt) * 2011-12-09 2020-01-14 Ceres Inc uso de um ácido nucleico isolado, método de obtenção de uma célula vegetal transgênica, método de obtenção de uma planta transgênica, método de produção de uma planta, método de produção de biomassa, método de processamento de biomassa, método de alteração da composição de biomassa, método de modulação de composição de biomassa, método de produção de um produto de forragem
KR20200012894A (ko) * 2017-05-26 2020-02-05 비라매틱스 에스디엔 비에이치디 펩타이드 및 항바이러스제로서의 이의 용도

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004535784A (ja) * 2001-03-22 2004-12-02 アメリカ合衆国 グリコシル化抵抗性シアノビリン及び関連コンジュゲート、組成物、核酸、ベクター、宿主細胞、非グリコシル化シアノビリンの製造方法及び使用方法
JP2005536456A (ja) * 2002-04-05 2005-12-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アテローム性硬化症を改善するｇ−タイプペプチド
CN103360469A (zh) * 2004-05-04 2013-10-23 诺维信阿德宁生物技术公司 抗微生物多肽
JP2011522561A (ja) * 2008-06-12 2011-08-04 ユニバーシティー プトラ マレーシア トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド
JP2011524373A (ja) * 2008-06-13 2011-09-01 ウィスコンシン・アルムナイ・リサーチ・ファウンデーション インフルエンザウイルスに対する新規抗ウイルスペプチド
JP2013538564A (ja) * 2010-07-28 2013-10-17 ユニヴァーシティ コート オブ ザ ユニバーシティ オブ エディンバラ 抗ウイルス剤
WO2014210454A1 (en) * 2013-06-27 2014-12-31 Rutgers, The State University Of New Jersey Treatment and diagnosis of ocular disease

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF IMMUNOLOGY, 2003, VOL.170, PP.1362-1373, JPN6020041109, ISSN: 0004376525 *
MOLECULAR IMMUNOLOGY, 2002, VOL.39, PP.323-331, JPN6020041106, ISSN: 0004623202 *
VIROLOGY JOURNAL, 2009, VOL.6, NO.74, PP.1-12, JPN6020041108, ISSN: 0004376524 *
VIROLOGY JOURNAL, 2011, VOL.8, NO.542, PP.1-11, JPN6020041111, ISSN: 0004376526 *

Also Published As

Publication number Publication date
US10538554B2 (en) 2020-01-21
EP3380493A4 (en) 2019-07-31
AU2016359545A1 (en) 2018-07-12
MY184269A (en) 2021-03-30
AU2016359545B2 (en) 2021-06-10
MY189021A (en) 2022-01-19
EP3380493A1 (en) 2018-10-03
US20180346516A1 (en) 2018-12-06
WO2017090010A1 (en) 2017-06-01
CN108699113A (zh) 2018-10-23
JP2022088370A (ja) 2022-06-14

Similar Documents

Publication Publication Date Title
EP2376100B1 (en) Peptidomimetic macrocycles
JP7219258B2 (ja) ペプチド模倣大環状分子およびその製剤
US10059741B2 (en) Peptidomimetic macrocycles
JP2022088370A (ja) 抗ウイルス剤としてのペプチドおよびこのための使用
CN105237629A (zh) 流感抑制组合物和方法
US9221874B2 (en) Antiviral peptides against influenza virus
US11376306B2 (en) Peptides and uses therefor as antiviral agents
ES2710973T3 (es) Análogos de las defensinas beta cíclicas para el tratamiento de infecciones
RU2492178C1 (ru) Противовирусный пептид, подавляющий репликацию вируса гриппа
HK40025030A (en) Peptides and uses therefor as antiviral agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191125

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191125

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20201021

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201102

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210506

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20211026